Search results
Author(s):
Christos-Konstantinos Antoniou
,
Polychronis Dilaveris
,
Panagiota Manolakou
,
et al
Added:
3 years ago
Ventricular repolarization, as opposed to depolarization, is not a triggered phenomenon following an orderly sequence, hence the dissimilarity between their inscribed electrocardiographic waves; rather, ventricular myocytes repolarize at a time and rate determined by their intrinsic electrophysiological properties (relative concentration of ion channel types and isoforms), as well as by the…
View more
Author(s):
Bogdan A Popescu
,
Carmen C Beladan
,
Carmen Ginghina
Added:
3 years ago
Chronic heart failure (CHF) is a major cause of morbidity and mortality in the general population with a prevalence of 1–2% in developed countries, where it accounts for 1–2% of total healthcare resources. Therefore, the economic burden of HF may become unmanageable, indicating the need for cost-effective preventative strategies and treatments.1 It has been acknowledged that about 50% of patients…
View more
Added:
1 year ago
HFSA 22 - In this interview, Dr Juuso Blomster (Precordior Ltd, Turku, FI) joins us to share the results of the REFLECS Trial (NCT04378179), originally presented at HFSA 2022.
This trial aimed to evaluate the Precordior CardioSignal app's efficacy in measuring patients cardiac motion and function in comparison to echocardiography. Over 200 patients were recruited to this observational study.
…
View more
Author(s):
Reginald Liew
Added:
3 years ago
Sudden cardiac death (SCD) can be defined as unexpected death that occurs within one hour of the onset of symptoms or during sleep in a person who was previously stable. The mode of death, which may be due to an arrhythmic or non-arrhythmic cause, depends on the underlying cardiovascular abnormality (mechanical or electrical substrate). SCD remains a major public health problem worldwide and is…
View more
Author(s):
John G Coghlan
Added:
3 years ago
The pace of progress in the field of pulmonary arterial hypertension (PAH) continues to be breathtaking. In the past couple of years two new oral agents have been granted licences. Fourteen major international drug trials are underway, many evaluating the role of combination therapies, and at least three agents (simvastatin, imatinib and aviptadil) are undergoing proof of concept studies in…
View more
Author(s):
Aneil Malhotra
,
Sanjay Sharma
Added:
3 years ago
Athletes who perform regular and intensive exercise regimes develop a variety of electrical and structural cardiac adaptations that manifest functionally to improve stroke volume and performance. Up to one-fifth of young athletes (aged between 14–35 years) reveal greater left ventricular (LV) wall thickness compared to sedentary controls, though the majority fall under 12 mm.1,2 A small…
View more
Hidden in Heart Failure
Author(s):
Douglas Ewan Cannie
,
Mohammed Majid Akhtar
,
Perry Elliott
Added:
3 years ago
Article
Author(s):
Sivabaskari Pasupathy
,
Rosanna Tavella
,
Simon McRae
,
et al
Added:
3 years ago
Early coronary angiography performed during acute MI (AMI) identifies an occluded vessel in most patients with ST elevation MI (STEMI)1 and less frequently in those with non-STEMI;2 however, ≥90 % of patients with AMI have evidence of obstructive coronary artery disease.3 For these patients with overt coronary artery disease (CAD), the benefits of reperfusion strategies and cardioprotective…
View more
Author(s):
Alessandro Cavalcanti Lianza
,
Maria de Fátima Rodrigues Diniz
,
Karen Saori Shiraishi Sawamura
,
et al
Added:
8 months ago
Author(s):
Felipe Martínez
,
Eduardo Perna
,
Sergio V Perrone
,
et al
Added:
3 years ago
Chagas disease was initially described as an endemic health problem in a few countries in South America – mainly Argentina and Brazil – and one of the consequences of the disease, heart damage, made it an interesting issue for healthcare professionals, from epidemiologists to cardiologists.1 Chagas cardiomyopathy (ChCM) is now recognised as a cardiovascular disorder, diagnosed and treated not…
View more